NeoGenomics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NeoGenomics and other ETFs, options, and stocks.

About NEO

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments.

CEO

Christopher Michael Smith

CEOChristopher Michael Smith

Employees

2,100

Employees2,100

Headquarters

Fort Myers, Florida

HeadquartersFort Myers, Florida

Founded

1998

Founded1998

Employees

2,100

Employees2,100

NEO Key Statistics

Market cap

1.79B

Market cap1.79B

Price-Earnings ratio

-19.50

Price-Earnings ratio-19.50

Dividend yield

—

Dividend yield—

Average volume

609.73K

Average volume609.73K

High today

$14.09

High today$14.09

Low today

$13.62

Low today$13.62

Open price

$13.70

Open price$13.70

Volume

191.17K

Volume191.17K

52 Week high

$21.22

52 Week high$21.22

52 Week low

$11.03

52 Week low$11.03

NEO News

Yahoo Finance 7h

NeoGenomics Announces Senior Leadership Promotions - Yahoo Finance

FT. MYERS, Fla., April 18, 2024--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced two promotions w...

Analyst ratings

77%

of 13 ratings

Buy

76.9%

Hold

23.1%

Sell